Authors
Latest:
Specialty Pharmacies: Meeting Payer Needs in an Evolving MarketWith the continued growth of the specialty pharmacy market, payers are employing an increasing number of cost and utilization management strategies to ensure proper use of specialty medications. Collaboration between specialty pharmacies and payers is essential.
Latest:
Challenges with the Introduction of Biosimilars in the USWith the introduction of biosimilars in the United States, there are several significant issues that will challenge those involved in formulary committees and benefit plans, as well as prescribers and pharmacists.
Latest:
Findings Related to Assessing Value for Private US Health PlansA qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
Latest:
Recognizing the Important Work of Pharmacists as Immunizers During World Immunization WeekEach time a pharmacist immunizes a patient against one of the 27 infections for which a safe and effective vaccine exists, the profession continues to protect communities against diseases that wreaked havoc on generations.
Latest:
CBD: Can It Help With Sleep?A plethora of new research and CBD products have come on the market in a very short time since the Hemp Farming Act of 2018 removed hemp from Schedule I controlled substances.
Latest:
The Case for Establishing a Residency Program in Specialty PharmacyPharmacy residency programs offer postgraduate training to launch pharmacists from their formal education into successful careers.
Latest:
Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary DiscussionPharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.
Latest:
Guidelines for Collaboration Among Physicians, Pharmacists, and Managed Care Organizations to Improve Asthma OutcomesNew ideas, new tools, and new collaborations among managed care, physicians, and pharmacy to optimize value in asthma management.
Latest:
Scott Gottlieb May be Selected to Head FDAExpedited drug approvals may become a reality if Scott Gottlieb confirmed as head of FDA.
Latest:
Recent Prosecutions on Product Discounts Show Legal Risk Hidden Beneath the SurfaceRecent prosecutions have heightened the risk for both market share discounts and discounts in lieu of service fees.
Latest:
Generic Product News: MarchProducts include oral suspension for gout and tablets that prevent low carnitine levels in the blood.
Latest:
Augmented Renal Clearance and the Impact on Antimicrobial TherapyWhether practicing pharmacy in the ambulatory or inpatient setting, professionals devote a substantial amount of energy and time to appropriate dosing of medications for renal impairment.
Latest:
Melatonin: Considerations for Use in Patients With Sleep DisordersMelatonin, an endogenous, or natural, hormone mainly produced by the pineal gland in the brain, regulates several body processes, including circadian rhythm and sleep patterns.
Latest:
Guselkumab Shows Efficacy as Active Psoriatic Arthritis TreatmentData from 2 studies evaluating guselkumab (Tremfya, Janssen) in active psoriatic arthritis were presented at the American College of Rheumatology and Association of Rheumatology Professionals 2019 Annual Meeting.
Latest:
Impact of Drug Therapy Duration in Patients With Hepatitis CAdherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.
Latest:
Cracking the Code of Optimized Influenza Prevention: Cell-Based Influenza Vaccine AdvancementCell-based vaccines have many potential advantages, one of which includes longer stability and more rapid manufacturing, as cellbased vaccines can be frozen and used at a later date, with dependable cell lines to ensure consistent supply.
Latest:
Cuvitru Approved for Primary ImmunodeficiencyThe FDA has just approved Shire's Cuvitru for primary immunodeficiency in patients 2 years and older.
Latest:
Relating to the Patient: My Most Influential ExperiencesA pharmacist offers her observations on patient-centered care.
Latest:
Lyme Vaccine Moves to Clinical TrialsThe FDA recently approved an Investigational New Drug application submitted by Valneva SE.
Latest:
When Will a Vaccine Be Ready?As we head into flu season, count on Pharmacy Times® to continue to report on the latest developments on COVID-19.
Latest:
Vaccination: What Do Consumers Want to Know?Researchers from Australia set out to determine health consumers' information needs and concerns related to childhood vaccination.
Latest:
Takeaways from NASP: The State of Pricing Reform Efforts and AI Decision Support in Specialty PharmacyThe National Association of Specialty Pharmacy's annual meeting is one of the industry’s only conferences where all stakeholders can fully participate.
Latest:
Long Acting Reversible Contraceptives and Chlamydia: No Increased RiskA team of researchers from Columbia University, New York City compared the incidence of chlamydia infection in adolescent LARC users to non-LARC users.
Latest:
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related TherapiesExamination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Latest:
Reimagining Specialty Pharmacy: Market Variability Drives New StrategiesA common theme during this year’s summit was the uncertainty about the profitability of the existing specialty pharmaceutical model.
Latest:
Effect of Dispensing Supply on Pravastatin Refill AdherenceIn uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.
